Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype–phenotype correlations

  • Raidt, Johanna
  • Riepenhausen, Sarah Luise
  • Pennekamp, Petra
  • Olbrich, Heike
  • Amirav, Israel
  • Athanazio, Rodrigo
  • Rovira Amigo, Sandra
Primary ciliary dyskinesia; DNA variants; Genotype, Discinesia ciliar primaria; Variantes de ADN; Genotipo, Discinesia ciliar primària; Variants d'ADN; Genotip, Background Primary ciliary dyskinesia (PCD) represents a group of rare hereditary disorders characterised by deficient ciliary airway clearance that can be associated with laterality defects. We aimed to describe the underlying gene defects, geographical differences in genotypes and their relationship to diagnostic findings and clinical phenotypes. Methods Genetic variants and clinical findings (age, sex, body mass index, laterality defects, forced expiratory volume in 1 s (FEV1)) were collected from 19 countries using the European Reference Network's ERN-LUNG international PCD Registry. Genetic data were evaluated according to American College of Medical Genetics and Genomics guidelines. We assessed regional distribution of implicated genes and genetic variants as well as genotype correlations with laterality defects and FEV1. Results The study included 1236 individuals carrying 908 distinct pathogenic DNA variants in 46 PCD genes. We found considerable variation in the distribution of PCD genotypes across countries due to the presence of distinct founder variants. The prevalence of PCD genotypes associated with pathognomonic ultrastructural defects (mean 72%, range 47–100%) and laterality defects (mean 42%, range 28–69%) varied widely among countries. The prevalence of laterality defects was significantly lower in PCD individuals without pathognomonic ciliary ultrastructure defects (18%). The PCD cohort had a reduced median FEV1 z-score (−1.66). Median FEV1 z-scores were significantly lower in CCNO (−3.26), CCDC39 (−2.49) and CCDC40 (−2.96) variant groups, while the FEV1 z-score reductions were significantly milder in DNAH11 (−0.83) and ODAD1 (−0.85) variant groups compared to the whole PCD cohort. Conclusion This unprecedented multinational dataset of DNA variants and information on their distribution across countries facilitates interpretation of the genetic epidemiology of PCD and indicates that the genetic variant can predict diagnostic and phenotypic features such as the course of lung function., This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG OM6/7, OM6/8, OM6/10, OM6/14, CRU 326 (to H. Omran, J. Raidt); OL 450/1 (H. Olbrich); CRC 1449 (project 431232613; sub-project Z02 to M.A. Mall)), the Interdisziplinaeres Zentrum für Klinische Forschung Muenster (Om2/009/12, Om2/015/16 and Om2/010/20), Registry Warehouse (Horizon2020 GA 777295) and the German Federal Ministry of Education and Research (82DZL009B1 to M.A. Mall). J.F. Roehmel is a participant of the Case Analysis and Decision Support (CADS) programme funded by the Berlin Institute of Health. The authors thank the “Børnelungefonden” and “Rigshospitalet's research fund” (K.G. Nielsen). A. Shoemark is supported by Asthma and Lung UK. The National UK PCD service is supported by NHS England. Some study authors and data contributors participate in the BEAT-PCD clinical research collaboration supported by the European Respiratory Society. This study was supported and promoted as part of work package 3 during the 2020-2023 BEAT-PCD funding period. H.M. Mitchison is supported by the NIHR Biomedical Research Centre at Great Ormond Street Hospital. S. Rovira-Amigo was funded by a grant from Instituto de Salud Carlos III (ISCIII) through the project “PI20/01419” and co-funded by the EU and a grant of the Spanish Society of Paediatrics (Invest-AEP 2021). V. Martinu was supported by Ministry of Health of the Czech Republic, grant number NV19-07-00210 and supported by Motol University Hospital, Prague, Czech Republic, 00064203 (conceptual development of research). E. Ziętkiewicz was supported by the Polish National Science Centre, grant 2018/31/B/NZ2/03248.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Primary Ciliary Dyskinesia and Retinitis Pigmentosa, Novel RPGR Variant and Possible Modifier Gene

  • Baz-Redón, Noelia|||0000-0003-1704-3413
  • Sánchez-Bellver, Laura|||0000-0003-3534-704X
  • Fernández Cancio, Mónica|||0000-0003-1872-3488
  • Rovira-Amigo, Sandra|||0000-0001-9896-0621
  • Burgoyne, Thomas|||0000-0002-8428-720X
  • Ranjit, Rai
  • Aquino, Virginia|||0000-0002-2329-8159
  • Toro-Barrios, Noemí
  • Carmona, Rosario|||0000-0003-2563-9591
  • Polverino, Eva|||0000-0002-4058-5109
  • Cols, Maria|||0000-0002-1060-3337
  • Moreno Galdó, Antonio|||0000-0002-2496-9786
  • Camats Tarruella, Núria|||0000-0002-4863-8201
  • Marfany, Gemma|||0000-0001-7941-983X
We report a novel RPGR missense variant co-segregated with a familial X-linked retinitis pigmentosa (XLRP) case. The brothers were hemizygous for this variant, but only the proband presented with primary ciliary dyskinesia (PCD). Thus, we aimed to elucidate the role of the RPGR variant and other modifier genes in the phenotypic variability observed in the family and its impact on motile cilia. The pathogenicity of the variant on the RPGR protein was evaluated by in vitro studies transiently transfecting the mutated RPGR gene, and immunofluorescence analysis on nasal brushing samples. Whole-exome sequencing was conducted to identify potential modifier variants. In vitro studies showed that the mutated RPGR protein could not localise to the cilium and impaired cilium formation. Accordingly, RPGR was abnormally distributed in the siblings' nasal brushing samples. In addition, a missense variant in CEP290 was identified. The concurrent RPGR variant influenced ciliary mislocalisation of the protein. We provide a comprehensive characterisation of motile cilia in this XLRP family, with only the proband presenting PCD symptoms. The variant's pathogenicity was confirmed, although it alone does not explain the respiratory symptoms. Finally, the CEP290 gene may be a potential modifier for respiratory symptoms in patients with RPGR mutations.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype–phenotype correlations

  • Raidt, Johanna
  • Riepenhausen, Sarah Luise
  • Pennekamp, Petra
  • Olbrich, Heike
  • Amirav, Israel
  • Athanazio, Rodrigo
  • Rovira Amigo, Sandra
Primary ciliary dyskinesia; DNA variants; Genotype, Discinesia ciliar primaria; Variantes de ADN; Genotipo, Discinesia ciliar primària; Variants d'ADN; Genotip, Background Primary ciliary dyskinesia (PCD) represents a group of rare hereditary disorders characterised by deficient ciliary airway clearance that can be associated with laterality defects. We aimed to describe the underlying gene defects, geographical differences in genotypes and their relationship to diagnostic findings and clinical phenotypes. Methods Genetic variants and clinical findings (age, sex, body mass index, laterality defects, forced expiratory volume in 1 s (FEV1)) were collected from 19 countries using the European Reference Network's ERN-LUNG international PCD Registry. Genetic data were evaluated according to American College of Medical Genetics and Genomics guidelines. We assessed regional distribution of implicated genes and genetic variants as well as genotype correlations with laterality defects and FEV1. Results The study included 1236 individuals carrying 908 distinct pathogenic DNA variants in 46 PCD genes. We found considerable variation in the distribution of PCD genotypes across countries due to the presence of distinct founder variants. The prevalence of PCD genotypes associated with pathognomonic ultrastructural defects (mean 72%, range 47–100%) and laterality defects (mean 42%, range 28–69%) varied widely among countries. The prevalence of laterality defects was significantly lower in PCD individuals without pathognomonic ciliary ultrastructure defects (18%). The PCD cohort had a reduced median FEV1 z-score (−1.66). Median FEV1 z-scores were significantly lower in CCNO (−3.26), CCDC39 (−2.49) and CCDC40 (−2.96) variant groups, while the FEV1 z-score reductions were significantly milder in DNAH11 (−0.83) and ODAD1 (−0.85) variant groups compared to the whole PCD cohort. Conclusion This unprecedented multinational dataset of DNA variants and information on their distribution across countries facilitates interpretation of the genetic epidemiology of PCD and indicates that the genetic variant can predict diagnostic and phenotypic features such as the course of lung function., This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG OM6/7, OM6/8, OM6/10, OM6/14, CRU 326 (to H. Omran, J. Raidt); OL 450/1 (H. Olbrich); CRC 1449 (project 431232613; sub-project Z02 to M.A. Mall)), the Interdisziplinaeres Zentrum für Klinische Forschung Muenster (Om2/009/12, Om2/015/16 and Om2/010/20), Registry Warehouse (Horizon2020 GA 777295) and the German Federal Ministry of Education and Research (82DZL009B1 to M.A. Mall). J.F. Roehmel is a participant of the Case Analysis and Decision Support (CADS) programme funded by the Berlin Institute of Health. The authors thank the “Børnelungefonden” and “Rigshospitalet's research fund” (K.G. Nielsen). A. Shoemark is supported by Asthma and Lung UK. The National UK PCD service is supported by NHS England. Some study authors and data contributors participate in the BEAT-PCD clinical research collaboration supported by the European Respiratory Society. This study was supported and promoted as part of work package 3 during the 2020-2023 BEAT-PCD funding period. H.M. Mitchison is supported by the NIHR Biomedical Research Centre at Great Ormond Street Hospital. S. Rovira-Amigo was funded by a grant from Instituto de Salud Carlos III (ISCIII) through the project “PI20/01419” and co-funded by the EU and a grant of the Spanish Society of Paediatrics (Invest-AEP 2021). V. Martinu was supported by Ministry of Health of the Czech Republic, grant number NV19-07-00210 and supported by Motol University Hospital, Prague, Czech Republic, 00064203 (conceptual development of research). E. Ziętkiewicz was supported by the Polish National Science Centre, grant 2018/31/B/NZ2/03248.